Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Aphria stock | $6.92

Own Aphria stock in just a few minutes.

Fact checked

Aphria Inc (APHA) is a leading drug manufacturers-specialty & generic business based in the US. It opened the day at USD$7.0724 after a previous close of USD$7.06. During the day the price has varied from a low of USD$6.89 to a high of USD$7.09. The latest price was USD$6.92 (25 minute delay). Aphria is listed on the NASDAQ and employs 1,200 staff. All prices are listed in US Dollars.

How to buy shares in Aphria

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Aphria. Find the stock by name or ticker symbol: APHA. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Aphria reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$6.92, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Aphria, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Aphria. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted Aphria's share price?

Since the stock market crash in March caused by coronavirus, Aphria's share price has had significant positive movement.

Its last close price was USD$6.92, which is 40.17% up on its pre-crash value of USD$4.14 and 254.87% up on the lowest point reached during the March crash when the shares fell as low as USD$1.95.

If you had bought USD$1,000 worth of Aphria shares at the start of February 2020, those shares would have been worth USD$552.17 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$1,504.34.

Aphria share price

Use our graph to track the performance of APHA stocks over time.

Aphria shares at a glance

Information last updated 2020-12-31.
Previous closeUSD$7.06
Change USD$-0.14
Change % -1.983%
Volume 5,108,209
Information last updated 2020-12-27.
52-week rangeUSD$1.95 - USD$8.88
50-day moving average USD$7.1661
200-day moving average USD$5.2981
Wall St. target priceN/A
PE ratio 23.8462
Dividend yield N/A (0%)
Earnings per share (TTM) USD$0.299

Buy Aphria shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
$0 for US stocks
Stocks, Options, ETFs
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Aphria stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Aphria price performance over time

Historical closes compared with the close of $6.92 from 2020-10-19

1 week (2021-01-08) -19.25%
1 month (2020-12-16) -14.04%
3 months (2020-10-16) 48.82%
6 months (2020-07-16) 36.49%
1 year (2020-01-16) 33.33%
2 years (2019-01-16) 4.06%
3 years (2018-01-16) 17.4418
5 years (2016-01-14) 714.02%

Is Aphria under- or over-valued?

Valuing Aphria stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Aphria's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Aphria's P/E ratio

Aphria's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Aphria shares trade at around 24x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Aphria financials

Gross profit TTM USD$191 million
Return on assets TTM 0.53%
Return on equity TTM -5.89%
Profit margin -18.93%
Book value $5.345
Market capitalisation USD$2.1 billion

TTM: trailing 12 months

Shorting Aphria shares

There are currently 21.7 million Aphria shares held short by investors – that's known as Aphria's "short interest". This figure is 12.6% down from 24.8 million last month.

There are a few different ways that this level of interest in shorting Aphria shares can be evaluated.

Aphria's "short interest ratio" (SIR)

Aphria's "short interest ratio" (SIR) is the quantity of Aphria shares currently shorted divided by the average quantity of Aphria shares traded daily (recently around 12.1 million). Aphria's SIR currently stands at 1.8. In other words for every 100,000 Aphria shares traded daily on the market, roughly 1800 shares are currently held short.

However Aphria's short interest can also be evaluated against the total number of Aphria shares, or, against the total number of tradable Aphria shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aphria's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Aphria shares in existence, roughly 80 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Aphria shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Aphria.

Find out more about how you can short Aphria stock.

Aphria share dividends

We're not expecting Aphria to pay a dividend over the next 12 months.

Aphria share price volatility

Over the last 12 months, Aphria's shares have ranged in value from as little as $1.95 up to $8.88. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aphria's is 2.6595. This would suggest that Aphria's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Aphria overview

Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site